Ximena Pinell, MD
Plastic Surgery · Washington, DCNPI 1275776973
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by AbbVie at 41.7% of the total. 2025 is the largest year on record at $3,013, 7.7 times the $390 reported in 2019.
Across 84 payments — averaging $80.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Motiva USA, LLC$1K
- W. L. Gore & Associates, Inc.$900
- Mentor Worldwide LLC$572
- Axogen$198
- Integra Lifesciences Corporation$171
- plus $595 from 9 others
What the payments were for
- Speaking & faculty fees$90013%
- Travel & lodging$1,80227%
- Food & beverage$3,93559%
- Gifts$871%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 42 | $2,803 |
| Motiva USA, LLC | 9 | $1,485 |
| W. L. Gore & Associates, Inc. | 1 | $900 |
| Mentor Worldwide LLC | 10 | $572 |
| Axogen | 4 | $198 |
| Integra Lifesciences Corporation | 2 | $171 |
| Galderma Laboratories, L.p. | 7 | $165 |
| Smith+Nephew | 1 | $130 |
| Innovation Technologies Inc | 1 | $88 |
| Revance Therapeutics, Inc. | 1 | $71 |
| Pacira Pharmaceuticals Incorporated | 2 | $43 |
| Sientra, Inc. | 1 | $37 |
| Davol Inc. | 1 | $29 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $21 |
| Stryker | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$2,648
- Motiva Implant Matrix$1,139
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$1,128
- REVOLVE$1,128
- Product in Development$900
- MENTOR CPX 2 Breast Tissue Expander$256
- DuraSorb Monofilament Mesh$152
- Stravix$130
- GRAFIX PL$130
- ARTOURA Breast Tissue Expander$125
- AVANCE NERVE GRAFT$121
- NATRELLE$120
How this compares
$6,724 in reported general payments places this provider in the 70th percentile of 34 plastic surgery providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 11 | $87 |
| Ibuprofen | 15 | $38 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Washington
- Paul RuffWashington$399K
- Kelly BoldenWashington$160K
- Rajiv ParikhWashington$54K
- Kenneth FanWashington$53K
- Wendy ChenWashington$43K
- Bharat RanganathWashington$26K
- Vikisha FrippWashington$21K
- Jessica WangWashington$7K
- Catherine HannanWashington$7K
- Rex HungWashington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.